OPKO Health Inc. (OPK)
NASDAQ: OPKHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
OPK stock chart
Technical analysisKey statistics
All statistics- Market cap
- $1.17B
- EPS (TTM)
- -$0.16
- Dividend yield
- None
- 52-week range
- 0.98 – 1.86
- Day range
- 1.55 – 1.62
- Volume / Avg
- 3.52M / 3.83M
- Beta
- —
- Shares outstanding
- 742.51M
52-week range
OPK stock today
Shares of OPKO Health (OPK) finished lower on Nov 20 at $1.57, a drop of 2.48% or $0.04 per share, versus the S&P 500's 3.70% decline. At this level, OPK sits in the middle of its 52-week range of $0.98 to $1.86: 15.6% below the high, set on Nov 6, 2026 and 60.2% above the low. OPK is up 24.6% year to date, outperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has gained 18.9%.
OPKO Health has posted a net loss over the last twelve months (EPS of -$0.16), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About OPKO Health
Company profileOPKO Health, Inc. operates as a healthcare company, in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company operates in two segments, Pharmaceutical and Diagnostics.
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- CEO
- Dr. Phillip Frost M.D., Ph.D.
- Headquarters
- Miami, FL
- Employees
- 2,275
- Website
- opko.com
Financial highlights
Full financialsIn fiscal 2025, OPKO Health generated $606.9 million in revenue, down 14.9% from fiscal 2024, its first annual decline since 2024. OPKO Health reported a net loss of $225.7 million, compared with a loss of $53.2 million a year earlier. Gross margin was 33.9% (up from 30.6%) and operating margin -19.3%.
| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Revenue | $606.88M | $713.14M | $863.50M | $1.00B | $1.77B |
| Growth | -14.90% | -17.41% | -14.01% | -43.42% | +23.64% |
| Net income | $-225.68M | $-53.22M | $-188.86M | $-328.40M | $-30.14M |
| EPS (diluted) | $-0.30 | $-0.08 | $-0.25 | $-0.46 | $-0.05 |
Analyst forecast
ForecastConsensus (6 analysts)
buy
Avg. price target
$4.15+164.33%
- Strong buy 3
- Buy 2
- Hold 1
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Last reported (Sep/2026)
- Nov 4, 2026
- EPS actual vs est.
- $-0.07 vs $-0.07
- Surprise
- 0.00%
OPK news
All OPK news- The Zacks Analyst Blog Highlights Hinge Health, OPKO Health, Globus Medical and Merit Medical SystemsNasdaqMMSI, OPK, GMED, HNGE
- MiniMed Launches MiniMed Flex Pump in Europe to Expand Diabetes Care (Revised)NasdaqMMED, MMSI, OPK, GMED
- Here's Why You Should Retain OPK Stock in Your Portfolio for NowNasdaqOPK, ISRG, WST, GKOS
- HNGE Stock Surges Nearly 146% YTD: Can Its Growth Story Continue?NasdaqHNGE, MMSI, OPK, GMED
- MiniMed Launches MiniMed Flex Pump in Europe to Expand Diabetes CareNasdaqMMED, MMSI, OPK, GMED
- OPKO Slips To Loss In Q3 On Impact Of Discontinued Operations, Revenue UpNasdaqLH, LLY, OPK, MKC.V
- Cocrystal Pharma Posts Wider Q3 Loss, Led By Norovirus Challenge Study CostsNasdaqCOCP, OPK
- Hims & Hers Q3 Earnings Miss Estimates, Gross Margin DownNasdaqHIMS, MMSI, OPK, GMED
OPKO Health peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| GPCRStructure Therapeutics Inc. ADR | 16.13 | -5.78% | $1.15B | vs OPK |
| HROWHarrow Inc. | 30.41 | -5.35% | $1.14B | vs OPK |
| CMPSCOMPASS Pathways Plc American Depository Shares | 8.05 | -6.94% | $1.14B | vs OPK |
| GHRSGH Research PLC | 17.53 | -5.55% | $1.20B | vs OPK |
| AMPHAmphastar Pharmaceuticals Inc. | 28.25 | +0.50% | $1.20B | vs OPK |
| MLYSMineralys Therapeutics Inc. | 13.66 | -3.53% | $1.21B | vs OPK |
| AAPGAscentage Pharma Group International American Depository Shares | 11.97 | -3.78% | $1.12B | vs OPK |
| OCULOcular Therapeutix Inc. | 5.57 | -4.95% | $1.23B | vs OPK |
Indexes, lists and sector
OPKO Health stock FAQ
What is OPKO Health's stock price today?
OPK last traded at $1.57 as of Nov 20, 4:00 PM EST, down 2.48% on the day. Prices are delayed at least 15 minutes.
Who is OPKO Health's CEO?
Dr. Phillip Frost M.D., Ph.D. is the chief executive officer of OPKO Health Inc., which has about 2,275 employees.
What is the OPK 52-week high?
The 52-week high for OPK is $1.86 and the 52-week low is $0.98. The stock is currently 15.6% below its high.